174 related articles for article (PubMed ID: 8784085)
21. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.
Papatheofanis FJ
J Nucl Med; 1997 Aug; 38(8):1175-9. PubMed ID: 9255144
[TBL] [Abstract][Full Text] [Related]
22. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
[TBL] [Abstract][Full Text] [Related]
23. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
[TBL] [Abstract][Full Text] [Related]
24. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
25. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
[TBL] [Abstract][Full Text] [Related]
26. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
Robins SP; Woitge H; Hesley R; Ju J; Seyedin S; Seibel MJ
J Bone Miner Res; 1994 Oct; 9(10):1643-9. PubMed ID: 7817812
[TBL] [Abstract][Full Text] [Related]
27. Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction.
Brazier M; Kamel S; Maamer M; Agbomson F; Elesper I; Garabedian M; Desmet G; Sebert JL
J Bone Miner Res; 1995 Nov; 10(11):1753-61. PubMed ID: 8592953
[TBL] [Abstract][Full Text] [Related]
28. Seasonal variation of biochemical indexes of bone turnover: results of a population-based study.
Woitge HW; Scheidt-Nave C; Kissling C; Leidig-Bruckner G; Meyer K; Grauer A; Scharla SH; Ziegler R; Seibel MJ
J Clin Endocrinol Metab; 1998 Jan; 83(1):68-75. PubMed ID: 9435418
[TBL] [Abstract][Full Text] [Related]
29. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.
Meier C; Meinhardt U; Greenfield JR; De Winter J; Nguyen TV; Dunstan CR; Seibel MJ
Clin Lab; 2006; 52(1-2):1-10. PubMed ID: 16506358
[TBL] [Abstract][Full Text] [Related]
30. Changes in bone turnover induced by aerobic and anaerobic exercise in young males.
Woitge HW; Friedmann B; Suttner S; Farahmand I; Müller M; Schmidt-Gayk H; Baertsch P; Ziegler R; Seibel MJ
J Bone Miner Res; 1998 Dec; 13(12):1797-804. PubMed ID: 9844096
[TBL] [Abstract][Full Text] [Related]
31. Improved purification of human bone sialoprotein and development of a homologous radioimmunoassay.
Karmatschek M; Maier I; Seibel MJ; Woitge HW; Ziegler R; Armbruster FP
Clin Chem; 1997 Nov; 43(11):2076-82. PubMed ID: 9365391
[TBL] [Abstract][Full Text] [Related]
32. Serum bone sialoprotein: a marker of bone resorption in postmenopausal osteoporosis.
Shaarawy M; Hasan M
Scand J Clin Lab Invest; 2001; 61(7):513-21. PubMed ID: 11763409
[TBL] [Abstract][Full Text] [Related]
33. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
[TBL] [Abstract][Full Text] [Related]
34. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
[TBL] [Abstract][Full Text] [Related]
35. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M
Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429
[TBL] [Abstract][Full Text] [Related]
36. Physiologic fluctuations of serum estradiol levels influence biochemical markers of bone resorption in young women.
Zittermann A; Schwarz I; Scheld K; Sudhop T; Berthold HK; von Bergmann K; van der Ven H; Stehle P
J Clin Endocrinol Metab; 2000 Jan; 85(1):95-101. PubMed ID: 10634371
[TBL] [Abstract][Full Text] [Related]
37. Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men.
Fall PM; Kennedy D; Smith JA; Seibel MJ; Raisz LG
Osteoporos Int; 2000; 11(6):481-5. PubMed ID: 10982162
[TBL] [Abstract][Full Text] [Related]
38. Increased serum bone sialoprotein concentrations in patients with Crohn's disease.
Faust D; Menge F; Armbruster FP; Lembcke B; Stein J
Z Gastroenterol; 2003 Mar; 41(3):243-7. PubMed ID: 12664344
[TBL] [Abstract][Full Text] [Related]
39. Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis.
Nur E; Mairuhu W; Biemond BJ; van Zanten AP; Schnog JJ; Brandjes DP; Otten HM;
Am J Hematol; 2010 Nov; 85(11):902-4. PubMed ID: 20882525
[TBL] [Abstract][Full Text] [Related]
40. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
Del Campo MT; González-Casaus ML; Aguado P; Bernad M; Carrera F; Martínez ME
Osteoporos Int; 1999; 9(5):449-54. PubMed ID: 10550465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]